Takahito et al. used the combination of PSMA antibody J591 and ICG to achieve targeted fluorescence imaging of prostate cancer, but it takes 2 days for J591-ICG to be fully absorbed, internalized, and activated by the tumor (Nakajima et al. 2011). Here, FOLH1 is linked to prostate carcinoma.